INO

Inovio Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality4/10
  • Growth↑ 7/10
  • Value↓ 3/10
Inovio Pharmaceuticals sales and earnings growth
INO Growth
Good
  • Revenue Y/Y↓ -100.00%
  • EPS Y/Y↑ 54.55%
  • FCF Y/Y↑ 18.58%
Inovio Pharmaceuticals gross and profit margin trends
INO Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ -86.18%
Inovio Pharmaceuticals net debt vs free cash flow
INO Risk
Great
  • Debt / Equity↓ 1.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Inovio Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks